Novel Inflammation Inhibitor Improves Psoriatic Arthritis Symptoms


Secukinumab improved peripheral joint disease, prevented joint damage, and produced clear or almost clear skin in a pair of pivotal Phase 3 trials.

The investigational psoriatic arthritis (PsA) treatment known as secukinumab improved peripheral joint disease, prevented joint damage, and produced clear or almost clear skin in a pair of pivotal, placebo-controlled Phase 3 trials, Novartis announced.

The experimental drug, which is also called AIN457, is a fully human monoclonal antibody selectively inhibits the interleukin-17A protein that is central to the development of PsA and other inflammatory arthritic diseases.

In the FUTURE 1 and FUTURE 2 studies that enrolled a combined total of more than 1000 patients, secukinumab met its primary and key secondary endpoints, which included improving the signs and symptoms of PsA compared with placebo. According to Novartis, the drug was well tolerated in both studies, and its safety profile was consistent with previously reported results from a large psoriasis clinical trial program that involved nearly 4000 patients.

“Effective new therapies are urgently needed for newly PsA-diagnosed patients and for nearly half of PsA patients who are dissatisfied with or not responding to their current treatments,” said Vasant Narasimhan, Global Head of Development at Novartis Pharmaceuticals, in a press release. "Building on the positive data previously reported in psoriasis, we are excited to present the first Phase 3 results of secukinumab in PsA.”

Based on those results, Novartis plans to file an application with the FDA in 2015 for use of secukinumab in PsA, Narasimhan said. That regulatory filling will follow the drug’s application for the treatment of moderate-to-severe plaque psoriasis, which was filed with the FDA in October 2013 and is anticipated to receive approval in late 2014 or early 2015.

In addition to PsA, secukinumab is also being investigated in clinical trials as a treatment for ankylosing spondylitis and rheumatoid arthritis.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.